Hims & Hers Stock Pops After Massive Acquisition [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
According to data provided by S&P Global Market Intelligence , shares are up 18.3% for the week as of 2:30 p.m. ET. Hims & Hers gets deeper into compounding The biggest news was Hims & Hers issuing 976,341 shares of common stock to acquire Nivagen Pharmaceuticals, which does business as MedisourceRX. The company is a compounding pharmacy, which will allow Hims & Hers to bring some product production in-house rather than outsourcing it to third parties. While investors may not be pleased by the dilution , strategically the deal makes a lot of sense. Products can now be produced in-house, and Hims & Hers can take that margin. It will also allow the company to be more flexible with what it produces and how products are combined into one solution. Volatility continues for Hims & Hers While this week was good for the stock, shares of Hims & Hers have been all over the place over the past six months. It's very possible the gains from this week were magnified by a rising market, an
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- Hims & Hers offers compounded Wegovy for $99 a month to select professions [Yahoo! Finance]Yahoo! Finance
- Hims & Hers offers compounded Wegovy for $99 a month to select professions [Yahoo! Finance]Yahoo! Finance
- Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First RespondersBusiness Wire
- 3 US Insider Picks With Earnings Growth Up To 98% [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 8/5/24 - Beat
HIMS
Sec Filings
- 9/23/24 - Form 4
- 9/23/24 - Form 4
- 9/20/24 - Form 144
- HIMS's page on the SEC website